Abstract:The hypothesis that neurotoxins may play a role in neurodegenerative disorders remains an elusive one, given that epidemiologic studies often provide conflicting results. Although these conflicting results may result from methodological differences within and between studies, the complexity of chemical disruption of the central nervous system cannot be ignored in attempts to evaluate this hypothesis in different neurodegenerative disorders. Spencer provides a detailed review of the complex processes involved in defining the neurotoxic potential of naturally occurring and synthetic agents. Even concepts such as exposure and dose, as often reported in studies attempting to evaluate the risk imparted by a potential compound, can be deceptive. For example, although dose reflects "that amount of chemical transferred to the exposed subject", factors such as time and concentration in the organism, the ability to access the central nervous system, and how a compound reaches the central nervous system (routes of administration) or secondarily affects other organ systems leading to central nervous system disruption are clearly important to the concept of neurotoxic risk in neurodegenerative disorders. These factors would appear to explain the observed disagreements between studies using animal or neuronal models of neurotoxicity and population-based studies in humans. The importance of these factors and how a potential neurotoxin is investigated are clearly seen in the data on AD and aluminum. In contrast, the impact of MTPT on the central nervous system is more direct and compelling. Added complexity in the study of neurotoxins in human neurodegeneration is derived from data showing that agents may have additive, potentiating, synergistic, or antagonistic effects. Therefore, data from studies evaluating EMF risks could be readily confounded by the presence or absence of heavy metals (eg, arc welding). Other factors that may conceal neurotoxic causes for a given disorder focus on additional features such as genetic predispositions, physiologic changes that occur in aging, and even nutritional status that can support or hinder the affect of a given agent on the central nervous system. Finally, many studies that investigate exposure risk do not readily incorporate the five criteria proposed by Schaumburg for establishing causation. For example, if we apply Schaumburg's first criterion, epidemiologic studies often determines the presence of an agent through history, yet they cannot readily confirm exposure based on environmental or clinical chemical analyses to fulfill this criterion for causation. Additional limitations in research design along with the populations and methods that are sued to study neurotoxins in human neurodegenerative disorders often fail to meet other criteria such as linking the severity and onset with duration and exposure level. Therefore, although studies of agents such as MTPT provide compelling models of neurotoxins and neurodegeneration in humans, disorders such as ALS, PD, and particularly AD will require additional effort if research is to determine the contribution (presence or absence) of neurotoxins to these neurologic disorders.

Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies

Implication of Pyrethroid Neurotoxicity for Human Health: A Lesson from Animal Models

Pyrethroid exposure and neurotoxicity: a mechanistic approach

Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms

Current Techniques for Assessing Developmental Neurotoxicity of Pesticides

Effects of pyrethroids on the cerebellum and related mechanisms: a narrative review

The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degeneration

The susceptibility of humans to neurodegenerative and neurodevelopmental toxicities caused by organophosphorus pesticides

New insights in animal models of neurotoxicity-induced neurodegeneration

Bifenthrin Caused Parkinson’s-Like Symptoms Via Mitochondrial Autophagy and Ferroptosis Pathway Stereoselectively in Parkin−/− Mice and C57BL/6 Mice

Effects of Pyrethroid Insecticides on Hypothalamic-Pituitary-gonadal Axis: A Reproductive Health Perspective

Fungicides as a risk factor for the development of neurological diseases and disorders in humans: a systematic review

Neurodegenerative memory disorders: a potential role of environmental toxins

Effects of chronic insecticide exposure on neuronal network development in vitro in rat cortical cultures

Linking pesticide exposure to neurodegenerative diseases: An in vitro investigation with human neuroblastoma cells

Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases

Dopaminergic and serotoninergic systems as preferential targets of the pyrethroid tefluthrin exposure in the rat brain

A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies

An Overview on the Role of Α -Synuclein in Experimental Models of Parkinson’s Disease from Pathogenesis to Therapeutics

Pyrethroids toxicity in vertebrates and invertebrates and amelioration by bioactive compounds: A review

Developmental neurotoxicity of the organophosphorus insecticide chlorpyrifos: from clinical findings to preclinical models and potential mechanisms